MARKET

NRXP

NRXP

Nrx Pharmaceuticals Inc
NASDAQ
2.350
+0.280
+13.53%
After Hours: 2.312 -0.038 -1.63% 19:59 03/14 EDT
OPEN
2.090
PREV CLOSE
2.070
HIGH
2.405
LOW
2.080
VOLUME
260.95K
TURNOVER
--
52 WEEK HIGH
7.20
52 WEEK LOW
1.100
MARKET CAP
39.75M
P/E (TTM)
-1.3906
1D
5D
1M
3M
1Y
5Y
1D
NRX Pharmaceuticals Price Target Maintained With a $19.00/Share by HC Wainwright & Co.
Dow Jones · 1d ago
HC Wainwright & Co. Reiterates Buy on NRX Pharmaceuticals, Maintains $19 Price Target
Benzinga · 1d ago
Weekly Report: what happened at NRXP last week (0303-0307)?
Weekly Report · 5d ago
NRx Pharmaceuticals to Post Q4 Earnings: How to Play the Stock?
NASDAQ · 03/03 17:01
Weekly Report: what happened at NRXP last week (0224-0228)?
Weekly Report · 03/03 10:23
Weekly Report: what happened at NRXP last week (0217-0221)?
Weekly Report · 02/24 10:23
Weekly Report: what happened at NRXP last week (0210-0214)?
Weekly Report · 02/17 10:21
Weekly Report: what happened at NRXP last week (0203-0207)?
Weekly Report · 02/10 10:18
More
About NRXP
NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal bipolar depression, chronic pain, and post-traumatic stress disorder (PTSD). The Company has two lead compounds, NRX-100, a proprietary presentation of ketamine and NRX-101, a fixed-dose combination of D-cycloserine (DCS) and lurasidone. The Company is developing NRX-101, a Food and Drug Administration (FDA)-designated investigational therapy for suicidal treatment-resistant bipolar depression and chronic pain. NRX-101 is a combined NMDA/5-HT2A-targeted medicine designed to address both depression and suicidal ideation, consisting of an oral, fixed dose combination of DCS and lurasidone. Its NRX-100 is racemic ketamine, which is a generic anesthetic. The Company is also engaged in the development of its new product, NRX-102.

Webull offers NRX Pharmaceuticals Inc stock information, including NASDAQ: NRXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRXP stock methods without spending real money on the virtual paper trading platform.